Market Place
Sourcing Support
All News #Library
Biotech
Kailera raises $625M IPO in biotech record
17 Apr 2026 //
ENDPOINTS NEWS
Kailera Therapeutics Announces Pricing Of Initial Public Offering
16 Apr 2026 //
GLOBENEWSWIRE
Kailera Plans $533M+ IPO For Competitive Obesity Market
14 Apr 2026 //
BIOSPACE
Kailera, Alamar launch IPOs As Biotech Listings Gather Momentum
13 Apr 2026 //
REUTERS
Kailera Plots IPO To Fund Hengrui-Licensed Obesity Pipeline
30 Mar 2026 //
FIERCE BIOTECH
Kailera, Hengrui To Advance Oral Obesity Drug Into 2 New Trials
10 Feb 2026 //
FIERCE BIOTECH
Kailera Therapeutics Starts Global Phase 3 Trial For Ribupatide
12 Jan 2026 //
GLOBENEWSWIRE
Kailera Therapeutics To Present At J.P. Morgan Healthcare
23 Dec 2025 //
GLOBENEWSWIRE
Kailera Therapeutics To Join November Investor Conferences
05 Nov 2025 //
GLOBENEWSWIRE
Hengrui & Kailera Share Ph3 China Data on Dual GLP-1/GIP Agonist
04 Nov 2025 //
GLOBENEWSWIRE
Hengrui Pharma, Kailera Therapeutics To Present Phase 3 HRS9531
21 Oct 2025 //
GLOBENEWSWIRE
Kailera Therapeutics Secures $600M To Advance Obesity Therapies
14 Oct 2025 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.